It was studied in phase 2 clinical trials for obesity in the 2000s
While BPC-157 appears to have more specific affinity for gastrointestinal healing, TB-500 (a synthetic version of Thymosin Beta-4) is studied more in the context of systemic recovery and muscle repair
Long-Term Management of B12 Deficiency Managing vitamin B12 deficiency in the long-term typically involves: Regular B12 supplementation, either through injections or oral therapy Dosage can vary from 1 to 5 mg daily Administered over a period of one to four months or until laboratory results indicate improvement in hematologic and/or neurologic functions Consult with a healthcare professional for personalized advice on managing vitamin B12 deficiency in the long-term and determining the most appropriate supplementation method for you
Patients with higher baseline cancer risk may require more frequent monitoring and more comprehensive surveillance protocols
Membership becomes your ultimate skin health ally
[Download Your Free Stack Card] Loading phase (weeks 1-4): - BPC-157: 250-500mcg subcutaneous, twice daily (morning and evening) - TB-500: 2.0-2.5mg subcutaneous, twice weekly (example: Monday and Thursday) - Total BPC-157 per day: 500-1000mcg - Total TB-500 per week: 4.0-5.0mg Maintenance phase (weeks 5-8+): - BPC-157: 250mcg subcutaneous, once daily - TB-500: 2.0-2.5mg subcutaneous, once weekly - Continue until healing goals are met or as directed by your provider Injection details: - Both peptides are injected subcutaneously in the abdomen - BPC-157 can optionally be injected near the injury site (subcutaneous) - TB-500 works systemically regardless of injection location - Rotate injection sites to prevent tissue irritation - Use insulin syringes for accurate dosing Reconstitution: Both peptides come as lyophilized powder